These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 17215342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of three commercial assays and a modified disk diffusion assay with two broth microdilution reference assays for testing zygomycetes, Aspergillus spp., Candida spp., and Cryptococcus neoformans with posaconazole and amphotericin B.
    Espinel-Ingroff A.
    J Clin Microbiol; 2006 Oct; 44(10):3616-22. PubMed ID: 16943356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of the Neo-Sensitabs diffusion method for determining the antifungal susceptibilities of Cryptococcus gattii isolates, using three different agar media.
    Pujol I, Pastor FJ, dos Santos Lazéra M, Guarro J.
    Rev Iberoam Micol; 2008 Dec 31; 25(4):215-20. PubMed ID: 19071889
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Swinne D, Raes-Wuytack C, Van Looveren K, Desmet P.
    Mycoses; 1999 Dec 31; 42(4):231-7. PubMed ID: 10424089
    [Abstract] [Full Text] [Related]

  • 9. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC, Lo HJ, Fung CP, Lee N, See LC.
    J Microbiol Immunol Infect; 2009 Apr 31; 42(2):148-53. PubMed ID: 19597647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE.
    J Clin Microbiol; 2005 Aug 31; 43(8):3884-9. PubMed ID: 16081926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Fothergill A, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE.
    J Clin Microbiol; 2005 Sep 31; 43(9):4535-40. PubMed ID: 16145103
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Borghi E, Iatta R, Sciota R, Biassoni C, Cuna T, Montagna MT, Morace G.
    J Clin Microbiol; 2010 Sep 31; 48(9):3153-7. PubMed ID: 20631105
    [Abstract] [Full Text] [Related]

  • 15. Comparison of tablet and disk diffusion methods for fluconazole and voriconazole in vitro activity testing against clinical yeast isolates.
    Rementeria A, Sanchez-Vargas LO, Villar M, Casals JB, Carrillo-Munoz AJ, Rodriguez Andres C, Eraso E, Quindos G.
    J Chemother; 2007 Apr 31; 19(2):172-7. PubMed ID: 17434826
    [Abstract] [Full Text] [Related]

  • 16. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F, Bretagne S.
    Clin Microbiol Infect; 2010 Jul 31; 16(7):863-9. PubMed ID: 19778296
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation and utility of the E-test and Neo-Sensitabs methods in studying fluconazole yeast susceptibility].
    Cantón E, Pemán J, Sastre M, Valentín A, Bosch M, Espinel-Ingroff A.
    Rev Esp Quimioter; 2006 Sep 31; 19(3):267-74. PubMed ID: 17099795
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun 31; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the NCCLS M44-P disk diffusion method for determining susceptibilities of 276 clinical isolates of Cryptococcus neoformans to fluconazole.
    Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2004 Jan 31; 42(1):380-3. PubMed ID: 14715784
    [Abstract] [Full Text] [Related]

  • 20. Cryptococcus neoformans serotype A and Cryptococcus gattii serotype B isolates differ in their susceptibilities to fluconazole and voriconazole.
    Khan ZU, Randhawa HS, Chehadeh W, Chowdhary A, Kowshik T, Chandy R.
    Int J Antimicrob Agents; 2009 Jun 31; 33(6):559-63. PubMed ID: 19195846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.